Last reviewed · How we verify
NCT04994457
Patient Performance on Virtual Reality Visual Field Devices as Compared to Standard of Care
trial testing Virtual Reality Visual Field in Glaucoma in 287 participants. Completed in 21 June 2024.
21 June 2024
Quick facts
| Lead sponsor | University of Miami |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 287 |
| Start date | 30 October 2021 |
| Primary completion | 21 June 2024 |
| Estimated completion | 21 June 2024 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Virtual Reality Visual Field
- Standard Automated Perimetry
Conditions studied
- Glaucoma — all drugs for Glaucoma →
Sponsor
University of Miami
Who can join
Adults 1 to 90, any sex, with Glaucoma. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this research is to study the effectiveness and patient experience when measuring visual fields using virtual reality goggles.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Reliability of Visual Field Testing in a Telehealth Setting Using a Head-Mounted Device: A Pilot Study.
McLaughlin DE, Savatovsky EJ, O'Brien RC, Vanner EA, et al · · 2024 · cited 14× · PMID 37647317 · DOI 10.1097/ijg.0000000000002290
Verify or expand the search:
- PubMed search for NCT04994457
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Glaucoma
Currently open trials in the same condition.
- NCT07455786 — Modified Trabeculectomy After Failure of Combined Phaco With GATT · NA · recruiting
- NCT07298356 — Automated Applanation Tonometry - Updated · NA · recruiting
- NCT07217678 — Biomarkers of Ocular Surface Damage in the Setting of Topical Ocular Hypotensive Medication Use · Phase 4 · recruiting
- NCT07145073 — Repetitive Transcranial Alternating Current Stimulation (rtACS) for the Treatment of Optic Neuropathies · NA · recruiting
- NCT07209410 — Evaluating Injection With the Use of Brimonidine Tartrate Ophthalmic 0.025% on Patients Using Netarsudil 0.02%/Latanopro · Phase 4 · recruiting
Other University of Miami trials
Trials by the same sponsor.
- NCT06003712 — Exploring the Effect of Mindfulness on Quality of Life (QoL) in Spinal Cord Injury (SCI) · NA · not yet recruiting
- NCT06077071 — MRIdian "RADAR" Trial · NA · not yet recruiting
- NCT07472413 — Alternate Pre-med in Anti-Cluster of Differentiation 20 (CD20) Pilot Project · Phase 3 · not yet recruiting
- NCT07322289 — Antibiotic-coated Braided Suture Study · NA · not yet recruiting
- NCT07469592 — eHealth Mindfulness-based Music Therapy Intervention for Patients Undergoing Stem Cell Transplantation · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04994457 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Miami
- Last refreshed: 27 June 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04994457.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing